Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06489431 · ClinicalTrials.gov registry record · Phase 3

Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement

A Phase 3 study of Erectile Dysfunction and Penile Prosthesis; Complications, Infection or Inflammation, sponsored by Rush University Medical Center.

Active
Registry status
Phase 3
Development phase
200
Enrollment target
3
Study locations

NCT06489431: Active Phase 3 study of Erectile Dysfunction and Penile Prosthesis; Complications, Infection or Inflammation, sponsored by Rush University Medical Center.

NCT06489431 is a Phase 3 study of Erectile Dysfunction and Penile Prosthesis; Complications, Infection or Inflammation that is active but no longer recruiting, run by Rush University Medical Center. The registered enrollment target is 200 participants, below the 226-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (12% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06489431, a Phase 3 study of Erectile Dysfunction and Penile Prosthesis; Complications, Infection or Inflammation, is active but no longer recruiting, sponsored by Rush University Medical Center.

ACTIVE NOT RECRUITING
Registry status
Phase 3
Development phase
200 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to assess whether intraoperative irrigation with Irrisept is not inferior to irrigation with multiple antibiotics during placement of a first time inflatable penile prosthesis device.

Primary Outcome

All patients will be closely followed with appointments at regular intervals for the first year after surgery to monitor for infections as per usual care

Interventions

  • DRUG Rifampin
  • DRUG Gentamicin
  • DRUG Chlorhexidine

Study Locations (3)

Illinois

  • Rush University Medical Center - Chicago
  • Uropartners Surgery Center - Des Plaines

California

  • Urological Surgeons of Northern California - Mountain View

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-12-04
Est. Completion 2027-12-31
Phase Phase 3
Rush University Medical Center

320 total trials

What the registry record for NCT06489431 still lists

NCT06489431 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 226-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (12% lower).

The record links to 2 conditions, with Erectile Dysfunction appearing as the primary indexed condition, and to 3 interventions - of which Rifampin is the first listed.

NCT06489431 reports a single indexed study location in Illinois, California.

Frequently Asked Questions

What is clinical trial NCT06489431 about?

NCT06489431 is a clinical study titled "Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement". The purpose of this study is to assess whether intraoperative irrigation with Irrisept is not inferior to irrigation with multiple antibiotics during placement of a first time inflatable penile prosthesis device.

What is the current status of trial NCT06489431?

This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2023-12-04. Estimated completion is 2027-12-31.

What conditions does trial NCT06489431 study?

This clinical trial studies the following conditions: Erectile Dysfunction, Penile Prosthesis; Complications, Infection or Inflammation.

What interventions are being tested in trial NCT06489431?

The interventions under investigation include: Rifampin (DRUG), Gentamicin (DRUG), Chlorhexidine (DRUG).

Who is sponsoring clinical trial NCT06489431?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06489431 being conducted?

This trial has 3 study locations across California, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Erectile Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06489431's enrollment target sits among peer trials

200 10th of 33 higher than 24 of 33 other Erectile Dysfunction trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Erectile Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06489431, the US trial registry maintained by the National Library of Medicine. NCT06489431 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.